Contracts & Grants

Information is courtesy of the Office of Sponsored Projects. Each listing includes the faculty member's name and school(s) appointments at The University of Texas Health Science Center at Houston, contracting or granting agency, funding amount and project title.

New

Nancy Bergstrom, School of Nursing (SON), International Severity Information Systems, $9,363, On-Time Prevention of Pressure Ulcers: Partnering with Quality Improvement Organizations.

Guy L. Clifton, Medical School (MS), Robert Wood Johnson Foundation, $155,000, Robert Wood Johnson Foundation Health Policy Fellowship.

Daniel Felleman, MS and Graduate School of Biomedical Sciences (GSBS), Whitehall Foundation Inc., $225,000, Cortical Modules Underlying Surface Brightness and Color Perception.

Gerard E. Francisco, MS, Innovative Neurotronics Inc., $39,041, A Three-Arm, Randomized Crossover Study Comparing the Innovative Neurotronics Walkaid System to Ankle/Foot Orthosis for Walking Performance and Quality of Life of Adults with Hemiparesis and Footdrop from Cerebrovascular Accident.

Jeffrey A. Frost, MS and GSBS, Susan G. Komen Breast Cancer Foundation, $250,000, The Role of the RhO Exchange Factor Net1 in Breast Cancer.

Francisco Fuentes, MS, Schering-Plough Corporation, $90,973, A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting with Acute Coronary Syndrome (Improved Reduction of Outcomes.

Raymond J. Grill, MS and GSBS, National Institutes of Health (NIH), National Institute of Neurological Disorders and Stroke (NINDS), $1,515,482, Phosphodiesterase-Inhibitors, Vascular Integrity and Spinal Cord Injury.

Carin A. Hagberg, MS, Hospira Inc., $44,835, A Randomized, Double-Blind, Comparison of Dexmedetomidine and Remifentanil for Sedation During Awake Fiberoptic Intubations - A Pilot Study.

Craig L. Hanis, School of Public Health (SPH) and GSBS, University of Arkansas, $159,240, Mapping T2DM Genes in GENNID (Genetics of Non-Insulin dependent Diabetes mellitus) Families: University of Texas Health Science Center at Houston Subcontract.

Sandra K. Hanneman, SON, American Association of Critical Care Nurses, $10,000, Multi-Site Randomized Clinical Trial of Horizontal Positioning to Prevent and Treat Pulmonary Complications in Mechanically Ventilated Patients: Pilot Study and Hemodynamic Substudy.

Theodore R. Harris, SPH, University of North Dakota, $13,853, Women’s Drinking: Secondary Analyses of 20-Year Data.

Keith Hoots, MS and GSBS, Medical College of Wisconsin, $31,125, Molecular and Clinical Biology of von Willebrand’s disease; Tulane University Medical Center, $11,589, A Prospective, Randomized, Cross-Over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients with Hemophilia A and Inhibitors (Profeiba); and Grifols Biologicals Inc., $46,777, A Study of Immunologic Safety for Alphanate in Previously Treated Patients Diagnosed with Severe Hemophilia A.

Hideki Innan, SPH, Alfred P. Sloan Foundation, $45,000, Gene Duplication and Concerted Evolution via Gene Conversion.

Lillian S. Kao, MS, Robert Wood Johnson Foundation, $300,000, Prevention H Surgical Site Infections.

Rodney E. Kellems, MS and GSBS, Texas Higher Education Coordinating Board, $100,000, Preeclampsia: Diagnostic and Therapeutic Opportunities.

James J. Knierim, MS and GSBS, Human Frontier Science Program Organization, $134,500, Cross Disciplinary Fellowship.

Nobuhide Kobori, MS, NIH, NINDS, $1,670,625, Norepinephrine and TBI-Associated Prefrontal Dysfunction.

Anil D. Kulkarni, MS and GSBS, Amino UP Chemical Co., Ltd., $26,000, Antioxidative Role of A-H-C-C and Oligonol Supplements.

David R. Lairson, SPH, Kelsey Rsearch Foundation, $56,292, Research Collaboration Between Kelsey and UT School of Public Health Project.

Jary M. Lesser, MS, Neurochem Inc., $207,000, A Phase III Study of the Efficacy and Safety of Aszhemed in Patients with Mild to Moderate Alzheimer’s Disease; and PPD Development, LP, $171,410, Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Daily Treatment with MPC-7869 on Measures of Cognition, Activities of Daily Living and Global Function in Subjects with Mild Dementia of the Alzheimer’s Type.

John W. Lindsey, MS and GSBS, Mount Sinai School of Medicine, $612,685, Combination Therapy in Multiple Sclerosis-CombiRx Phase III, A Multicenter, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1A and Glatiramer Acetate to Either Alone, in Patients with Relapsing- Remitting Multiple Sclerosis.

Luis A. Mieles, MS, Wyeth Pharmaceuticals, $356,045, A Randomized, Open-Label, Comparative Evaluation of Conversion from Calcineurin Inhibitor Treatment to Sirolimus Treatment Versus Continued Calcineurin Inhibitor Treatment in Liver Allograft Recipients Undergoing Maintenance Therapy.

Dianna M. Milewicz, MS and GSBS, NIH, National Heart, Lung and Blood Institute, $11,624,361, SCCOR in Thoracic Aortic Aneurysms and Dissections.

Joe C. Ontiveros, Dental Branch (DB) and GSBS, Cooley & Cooley, Ltd., $500, Compressive Strength of White Copper Cement; Cooley & Cooley, Ltd., $1,600, Bond Strength of SNAP Bond to Enamel and Dentin; and Cooley & Cooley, Ltd., $1,000, Film Thickness of Copalite Varnish with Red and White Copper Cement Combinations.

Luis Ostrosky-Zeichner, MS, Merck & Co. Inc., $68,000, Contemporary Revalidation of Clinical Prediction Rules for Invasive Candidiasis in the Intensive Care Setting: Preparatory Work for Identifying High Risk Hosts for a Clinical Trial in Antifungal Prophylaxis.

Rade Paravina, DB, Nusmile Primary Crowns, $8,000, Consultation on Development of New Shades for Nusmile Primary Crowns.

Adriana Perez, SPH, American Statistical Association, $67,560, Missing Data Imputation at the Survey of Industrial Research and Development.

John M. Powers, DB and GSBS, Centrix Inc., $2,400, Bond Strength of an Adhesive to Dentin with Supercure, Encore D/C and Encore Rapid.

Joshua Samuels, MS, NIH, National Institute of Diabetes and Digestive and Kidney Diseases, $626,784, Acute Kidney Failure in a Cancer ICU.

Richard W. Smalling, MS, Evalve Inc., $40,325, Everest 1 A Study of the Evalve Cardiovascular Valve Repair System Endovascular Valve Edge to Edge Repair Study.

Heinrich Taegtmeyer, MS and GSBS, Heart Failure Society of America, $64,999, The Molecular LVAD-Autophagy Regulates Remodeling in the Unloaded Heart.

Patrick M. Tarwater, SPH, University of Pittsburgh, $39,293, CV-N Secreting Lactobacilli and Retrocyclin Microbicides.

Mark E. Wong, DB, Oral and Maxillofacial Surgery Foundation, $12,500, Student Research Training Award.

Robert Joseph Yetman, MS, Glaxo Smith Kline, $99,100, A Phase III, Randomized, Multinational Study, Double-Blinded for the Immunogenicity and Consistency Evaluation of 3 HIB-MENCYTT Vaccine Lots and Single-Blinded ANC-Controlled for the Evaluation of Safety and Immunogenicity of GSK Biologicals’ Haemohpilu.

Xiurong Zhao, MS, American Heart Association, Texas, $130,000, PPARG in Microglia/Macrophage as an Anti-Inflammatory Factor to Promote Hematoma Resolution after Hemorrhagic Stroke.

Renewal

Terry Crow, MS, NIH, National Institute of Mental Health (NIMH), $1,577,815, Cellular/Molecular Analysis of Short-and Long-Term Memory.

Patricia W. Evans, MS, Harris County Hospital District, $45,007, High Risk Infant Liaison Nurse.

Bruce C. Kone, MS and GSBS, Harris County Hospital District, $514,126, Ryan White Title 1 Formula (DHHS) Outpatient Ambulatory Grants.

Michael Mauk, MS and GSBS, NIH, NIMH, $1,642,428, Cerebellar Mechanisms of Motor Learning.

Stanley G. Schultz, MS and GSBS, NIH, National Center for Research Resources, $9,195,275, General Clinical Research Center.